Insider Stock Trading History of Kendall Keith J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Kendall Keith J since year 2005. The trader's CIK number is 1406834. At the time of this reporting, Kendall Keith J is the CEO and President of Aquestive Therapeutics, Inc. . (stock ticker symbol AQST). See this page for all insider trading activities at Aquestive Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Kendall Keith J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-11-30 AQST Aquestive Therapeutics, Inc. Option Ex 14,572 .00 0
2018-11-27 AQST Aquestive Therapeutics, Inc. Buy 1,000 9.87 9,870
2018-11-21 AQST Aquestive Therapeutics, Inc. Buy 6,000 10.17 61,020
2018-11-23 AQST Aquestive Therapeutics, Inc. Buy 1,950 9.90 19,305
2018-09-30 AQST Aquestive Therapeutics, Inc. Option Ex 329 .00 0
2018-08-31 AQST Aquestive Therapeutics, Inc. Option Ex 14,572 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kendall Keith J (CEO and President of Aquestive Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.